Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
10/15/1991 | US5057605 Sialocylglycerolipids and method for preparing the same |
10/15/1991 | US5057538 Hydroxystyrene compounds which have useful pharmaceutical utility |
10/15/1991 | US5057536 Macrolide compounds |
10/15/1991 | US5057530 Glycerol derivatives |
10/15/1991 | US5057528 Amino-pyridine compounds useful as anti-arrhythmic agents |
10/15/1991 | US5057526 Pharmaceutically active pyridinyl substituted 5,7-dihydropyrrolo-[3,2-f]benzoxazole-6-ones |
10/15/1991 | US5057521 Use of bicyclic imidazole compounds for the treatment of hyperaldosteronism |
10/15/1991 | US5057519 5-HT3 antagonists: use in reducing opiate tolerance |
10/15/1991 | US5057516 Nervous system disorders |
10/15/1991 | US5057513 Spiro-thiazepine derivatives useful as paf antagonists |
10/15/1991 | US5057511 Antibiotics, bactericides |
10/15/1991 | US5057510 Use of selected pyridine-2-thione-N-oxide compounds as growth promoters for poultry |
10/15/1991 | US5057509 Bile acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them |
10/15/1991 | US5057507 Method of alleviating bone damage with inositoltriphosphate |
10/15/1991 | US5057501 Mixture of sesquiterpene and fatty acid, ester, or amide |
10/15/1991 | US5057500 Treatment of pruritis with esters and amides |
10/15/1991 | US5057499 Parasiticides |
10/15/1991 | US5057498 Antiparastic agents |
10/15/1991 | US5057494 Method for preventing tissue damage after an ischemic episode |
10/15/1991 | US5057325 Method of inhibiting replication of HIV with water-soluble melanins |
10/15/1991 | US5057322 Method of treating mast cell disease |
10/15/1991 | US5057320 Means and method for increasing skin respiration |
10/15/1991 | US5057319 Pharmaceutical compositions of cimetidine |
10/15/1991 | US5057304 Active compounds for use in the treatment of tumors |
10/15/1991 | US5056682 Container for fan-folded sheets |
10/15/1991 | CA1290761C Chemical complex of potassium acetylsalicylate and preparation thereof |
10/15/1991 | CA1290759C Imidazole-ethanol esters |
10/15/1991 | CA1290756C Quinazolinone derivative and processes for preparing the same |
10/15/1991 | CA1290754C Method of manufacturing benzoguanamine derivatives |
10/15/1991 | CA1290753C Tetrapyrrole therapeutic agents |
10/15/1991 | CA1290751C Process for preparing netilmicin |
10/15/1991 | CA1290748C 3-propenylcephem derivative |
10/15/1991 | CA1290693C BIS(.beta.-HYDROXYETHYL)SULFOXIDE COSMETIC COMPOSITIONS FOR THE TREATMENT OF OILY SKIN AND HAIR, AND APPLICATION THEREOF |
10/15/1991 | CA1290692C Substrate composition for treating atherosclerosis |
10/15/1991 | CA1290691C Methods of treating bone diseases by administration of a cysteine proteinase inhibitor |
10/15/1991 | CA1290690C Method of reducing the swelling or pain associated with antibiotics compositions |
10/14/1991 | WO1991016313A1 Substituted benzimidazoles |
10/14/1991 | CA2077897A1 Substituted benzimidazoles |
10/14/1991 | CA2040242A1 Treatment with benzodiazepine compounds |
10/13/1991 | WO1991016341A1 Peptide derivatives |
10/13/1991 | WO1991016103A1 Improved iontophoretic administration of drugs |
10/13/1991 | CA2080012A1 Iontophoretic administration of drugs |
10/13/1991 | CA2059302A1 Peptide derivatives |
10/13/1991 | CA2040397A1 Ammonium salts of n5-methyl-5,6,7,8-tetrahydrofolic acid |
10/13/1991 | CA2040284A1 Combination of formate esters and pepper-like constituents as an orally-consumable chloroform substitute |
10/13/1991 | CA2040219A1 3,5-disubstituted 2-isoxazolines and isoxazoles, processes for their preparation, agents containing them and their use |
10/13/1991 | CA2040059A1 Difluoroglutamic acid conjugates with folates and anti-folates for the treatment of neoplastic diseases |
10/12/1991 | WO1991015194A1 Taste masking of ibuprofen by fluid bed coating |
10/12/1991 | CA2076983A1 Taste masking of ibuprofen by fluid bed coating |
10/12/1991 | CA2040170A1 Ergoline-8-carboxamides |
10/12/1991 | CA2040103A1 Hydroxylamine compounds |
10/12/1991 | CA2040062A1 Haemorheological use of n-alkylated 1,4-dihydropyridinedicarboxylic acid esters, and some new compounds |
10/11/1991 | WO1991015484A1 Pyridines as medicaments |
10/11/1991 | CA2080127A1 Pyridines as medicaments |
10/11/1991 | CA2040123A1 Ethylene-substituted phenylalkylethylenediamine-platinum (ii or iv) derivatives and phenylalkylethylenediamines |
10/11/1991 | CA2040116A1 Sustained release of active agents from bioadhesive microcapsules |
10/11/1991 | CA2039980A1 Use of short chain fatty acid containing lipids to maintain gastrointestinal integrity and function in patients |
10/11/1991 | CA2039968A1 2-substituted alkyl-3-carboxy carbapenems as antibiotics and a method of producing them |
10/11/1991 | CA2039955A1 Pharmaceutical compounds |
10/11/1991 | CA2039873A1 Cycloalkano(b)dihydroindoles and -indolesulphonamides substituted by heterocycles |
10/10/1991 | WO1991015499A1 2'-o-alkyl nucleotides and polymers containing them |
10/10/1991 | WO1991015486A1 Thiophene sulfonamides useful as carbonic anydrase inhibitors |
10/10/1991 | WO1991015207A1 Remedy for obstructive pulmonary disease |
10/10/1991 | WO1991015199A1 Antidiarrheal composition and method |
10/10/1991 | DE4037363A1 New 2-O-alkyl nucleotide(s) and polymers contg. them - for nuclease-resistant anti-sense probes and to treat viral infection including herpes influenza and AIDS and cancer |
10/10/1991 | DE4011285A1 Arzneimittel zur behandlung von hyperlipidaemie und/oder atherosklerose Medicines for treating hyperlipidemia and / or atherosclerosis |
10/10/1991 | DE4010536A1 Pharmazeutische waessrige loesung von 4-(2-(benzolsulfonylamino)-ethyl)-phenoxyessigsaeure A pharmaceutical aqueous solution of 4- (2- (benzenesulfonylamino) ethyl) -phenoxyacetic acid |
10/10/1991 | CA2081388A1 Antidiarrheal composition and method |
10/10/1991 | CA2080130A1 Remedy for obstructive pulmonary diseases |
10/10/1991 | CA2039987A1 Carbapenem compounds |
10/10/1991 | CA2039937A1 3-aminochroman derivatives, their preparation process and pharmaceutical compositions containing them |
10/09/1991 | EP0451130A2 Use of amiloride and other pyrazine derivatives for preventing or treating ocular neovascularization |
10/09/1991 | EP0451103A1 Parenterally applicable liposome formulation of synthetic lipids |
10/09/1991 | EP0451082A1 Ophthalmic product |
10/09/1991 | EP0451022A1 Novel compounds for the treatment of migraine |
10/09/1991 | EP0451009A2 Pharmaceutical composition comprising opiate antagonists for the treatment of emotional numbness |
10/09/1991 | EP0451008A1 8-Sulfamylmethylene-2-amino tetralins |
10/09/1991 | EP0451007A1 Sulphonylphenyl-beta-D-thioxylosides, process for their preparation and their use in therapy |
10/09/1991 | EP0450995A1 New propanamines, their pharmacological properties and their therapeutical applications, notably as anti-diarrhoea agents |
10/09/1991 | EP0450991A2 Use of phosphatidylglycerol(diC 18:10)in the treatment of obstructive airway diseases |
10/09/1991 | EP0450986A2 A percutaneous-administration-type pharmaceutical preparation of nitroglycerin |
10/09/1991 | EP0450812A1 Antihypercholesterolemics |
10/09/1991 | EP0450792A2 Glomerellan as an immunostimulant and/or an anti-tumor agent |
10/09/1991 | EP0450761A1 Spirocyclic oxytocin antagonists |
10/09/1991 | EP0450757A2 Use of 5-hydroxytryptamine-antagonists in the treatment of mental disorders originating in childhood |
10/09/1991 | EP0450689A1 New isochromane derivatives |
10/09/1991 | EP0450660A1 Anti-atherosclerotic diaryl compound |
10/09/1991 | EP0450598A2 Inhibitors of the advanced glycosylation of proteins and methods of use therefor |
10/09/1991 | EP0450588A1 Substituted 3-thia- or 3-oxa-alkyl flavones, process for their preparation, their application and drugs based on these compounds as well as intermediates |
10/09/1991 | EP0450566A1 Substituted azoles, method for their preparation, these containing compositions and their use |
10/09/1991 | EP0450559A1 3-hydroxy derivates of mevinic acid |
10/09/1991 | EP0450515A2 Haloethyl-substituted steroidal enzyme inhibitors |
10/09/1991 | EP0450508A2 Use of dermatan sulphate for the prevention and therapy of cerebral aging and of central nervous system functional deficit states |
10/09/1991 | EP0450487A1 Benzoxazine derivatives, method for their preparation and their use for treating or prophylaxis of diseases |
10/09/1991 | EP0450429A1 Cyclophanes, process for their preparation and pharmaceuticals containing them |
10/09/1991 | EP0450420A2 Dihydropyridines substituted by heterocycles, process for their preparation and their use in medicaments |
10/09/1991 | EP0450415A1 Substituted cyanoimino benzopyranes |
10/09/1991 | EP0450398A2 Chondroitin sulfate complexes having anti-inflammatory activity, processes for the preparation thereof and pharmaceutical compositions containing them |
10/09/1991 | EP0450352A1 Liposome formulations of immunomodulating drugs for the topical and aerosol administrations |
10/09/1991 | EP0450345A1 Indole derivatives |